Pan-cancer transcriptomic analysis using GEPIA2 (33) revealed that GPATCH3 is significantly upregulated in a broad spectrum of malignancies compared to corresponding normal tissues (Figure 4A). This evidence concerns the gene GPATCH3 and cancer.